ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pancreatic Cancer
Stomach Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer
Prostatic Cancer
Esophageal Cancer
Cancer

Adenocarcinoma trials near San Antonio, TX, USA:

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma (PHOLIPANC)

This is a clinical trial that tests a surgical treatment. Everyone in the study will get the same treatment, and there is no comparison or placebo gr...

Enrolling
Adenocarcinoma of the Pancreas
Procedure: Surgical resection
The University of Texas System (UT)
The University of Texas System (UT)

San Antonio, Texas, United States

and efficacy of relacorilant in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic adenocarcinoma...

Enrolling
Adenocarcinoma
Carcinoma, Pancreatic Ductal
Drug: Gemcitabine 1000 mg/m^2
Drug: Relacorilant 150 mg once daily (QD)

Phase 2

Corcept Therapeutics
Corcept Therapeutics

San Antonio, Texas, United States and 9 other locations

Locations recently updated

The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 3

Arcus Biosciences
Arcus Biosciences

San Antonio, Texas, United States and 118 other locations

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer,...

Enrolling
Pancreatic Adenocarcinoma
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Drug: ASP546C

Phase 1, Phase 2

Astellas
Astellas

San Antonio, Texas, United States of America and 7 other locations

Locations recently updated

with chemotherapy in participants with previously untreated advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma...

Enrolling
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Drug: Nivolumab
Drug: Pumitamig

Phase 2, Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

San Antonio, Texas, United States and 160 other locations

This study is open to adults with advanced pancreatic cancer. The study tests a type of immunotherapy. It is a protein treatment combined with a viru...

Active, not recruiting
Pancreatic Ductal Adenocarcinoma
Drug: ATP150
Drug: ATP152

Phase 1

Boehringer Ingelheim
Boehringer Ingelheim

San Antonio, Texas, United States and 24 other locations

after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponso...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Rilvegostomig

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 98 other locations

Locations recently updated

is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal adenocarcinoma...

Enrolling
Solid Tumors
Drug: Investigator's choice of chemotherapy
Drug: Placebo

Phase 3

Incyte
Incyte

San Antonio, Texas, United States and 211 other locations

The purpose of the study is to explore the safety and effects of the study drug (PF-08046876) in people diagnosed with advanced cancer of the bladder...

Enrolling
Pancreatic Adenocarcinoma
Esophageal Adenocarcinoma
Drug: PF-08046876

Phase 1

Pfizer
Pfizer

San Antonio, Texas, United States and 27 other locations

This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without bu...

Active, not recruiting
Pancreatic Cancer
Combination Product: TTX-030, nab-paclitaxel and gemcitabine
Combination Product: TTX-030, budigalimab, nab-paclitaxel and gemcitabine

Phase 2

Trishula Therapeutics

San Antonio, Texas, United States and 63 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems